Systems biomarkers for papillary thyroid cancer prognosis and treatment through multi-omics networks-Reference-Cited by-同舟云学术

Systems biomarkers for papillary thyroid cancer prognosis and treatment through multi-omics networks

Published:2022-01 Issue: Volume:715 Page:109085
ISSN:0003-9861
Container-title:Archives of Biochemistry and Biophysics
language:en
Short-container-title:Archives of Biochemistry and Biophysics

Author:

Gulfidan Gizem^ORCID,Soylu Melisa,Demirel Damla,Erdonmez Habib Burak Can,Beklen Hande^ORCID,Ozbek Sarica Pemra^ORCID,Arga Kazim Yalcin,Turanli Beste^ORCID

Publisher

Elsevier BV

Subject

Molecular Biology,Biochemistry,Biophysics

Reference116 articles.

1. Cancer statistics;Siegel;CA Canc. J. Clin.,2021

2. Management of the neck in thyroid cancer;Shaha;Otolaryngol. Clin.,1998

3. Thyroid cancer;Cabanillas;Lancet,2016

4. Discovery of therapeutic agents for prostate cancer using genome-scale metabolic modeling and drug repositioning;Turanli;EBioMedicine,2019

5. Multi-omic data interpretation to repurpose subtype specific drug candidates for breast cancer;Turanli;Front. Genet.,2019

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. ACAP3 negatively regulated by HDAC2 inhibits the malignant development of papillary thyroid carcinoma cells;The International Journal of Biochemistry & Cell Biology;2024-09

2. Integrated systems biology analysis of acute lymphoblastic leukemia: unveiling molecular signatures and drug repurposing opportunities;Annals of Hematology;2024-06-05

3. Promising Role of Alkaloids in the Prevention and Treatment of Thyroid Cancer and Autoimmune Thyroid Disease: A Comprehensive Review of the Current Evidence;International Journal of Molecular Sciences;2024-05-15

4. Multi-omics Profiles are Applicable to Human Diseases and Drug Development;Recent Advances in Biotechnology;2024-03-12

5. Role of sodium/iodide symporter overexpression in inhibiting thyroid cancer cell invasion and stem cell maintenance by inhibiting the β-catenin/LEF-1 pathway;Heliyon;2024-03